Page 8 - Read Online
P. 8
ABOUT THE SPECIAL ISSUE EDITORS
Stefania Nobili, Pharm.D., Ph.D. is a pharmacologist working at the
Department of Health Sciences, University of Florence (Italy). She received
her Pharm.D. degree from the University of Rome ‘La Sapienza’ in 1989, her
specialization in Applied Pharmacology from the University of Florence in
1997, and her Ph.D. in Chemotherapy from the University of Milan in 2001.
During her Ph.D. she was visiting fellow in the Laboratories of the Center of
Translational Research of the Department of Oncology, Queen’s University
(Belfast, UK), directed by Prof. Patrick G. Johnston†.
In 2013 she was awarded the Alberico Benedicenti Award for Pharmacology
and Toxicology from the Italian Society of Pharmacology (Milan, Italy) and
in 2017 she received an award from the Italian Ministery of University and
Research (MIUR) for scientific production 2012-2016. She has published 70
peer-reviewed original articles, reviews, editorials and more than 20 book
chapters. She serves as Section Editor for Pharmacology and Pharmaceutics
of All Life journal and as Associate Editor and Editorial board member for several international journals. Also, she is
a reviewer in cancer pharmacology and medical oncology for more than 40 journals and acts as external evaluator for
international scientific institutions (e.g. H2020-Marie Skłodowska-Curie COFUND Programme for Netherland Universities,
H2020 European Projects, e.g. H2020 FET OPEN RIA, Bruxelles). She is also listed among the experts and consultants of
the Italian Medicines Agency (AIFA). She was responsible for project granted by national and international institutions.
Her research interests are focused on preclinical and clinical pharmacology of anticancer drugs, in particular cancer
pharmacogenetics and pharmacogenomics, tumor drug resistance, with emphasis on drugs used in the treatment of
gastrointestinal neoplasms.
Dr. Nobili is a member of the Italian Society of Pharmacology (SIF), the Cancer Pharmacology Working Group of SIF,
the Italian Society of Chemotherapy, the Pharmacology & Molecular Mechanisms (PAMM) Group of the European
Organization for Research and Treatment of Cancer (EORTC) and the PathoBiology Group of EORTC.
